You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
iShares NASDAQ Biotechnology Index Returns vs. S&P
|1 Year||5 Year||5 Year Annualized||Since IPO|
iShares NASDAQ Biotechnology Index Company Info
The investment seeks investment results that correspond generally to the price and yield performance before fees and expenses of the NASDAQ Biotechnology Index (the underlying index).
News & Analysis
Marketed products -- and work in the pipeline -- should translate into future growth for these shares.
The ETF is the largest in its space and offers biotech investors a less volatile avenue.
These exchange-traded funds offer investors an easy way to potentially profit from growth in the healthcare sector.
The recent crop of new stocks runs the gamut from R&D stage biotech to a Fortune 500 spin-off with billions in revenue.
If you lack the time or technical knowledge to invest in biotech, this might be the fund for you and your diversified portfolio.
The largest biotech ETF looks good for investors who don't mind the industry's manic behavior.
Find out whether this is a smart way to invest in biotech stocks.
Looking for a few geat index funds to buy? Here's why our team thinks that you should consider these three.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.